STAT

Hospital workers across the U.S. present sharply different pictures of their preparedness for the coronavirus

Hospitals' readiness for the #coronavirus depends on their leadership, said one doctor — whether or not they're in “the ‘just the flu’ contingent."
Medical workers at the Kaiser Permanente French Campus test a patient for the novel coronavirus at a drive-through testing facility in San Francisco on Thursday.

U.S. hospitals are bracing for an onslaught of patients sickened by the new coronavirus, shoring up supplies, refining crisis plans, and putting on a brave face. But there’s another narrative at play: Many health workers feel left in the lurch.

STAT heard in recent days from dozens of frontline hospital employees, and depending on where they worked, they presented sharply different pictures of preparedness. There are those who believe their health systems are equipped to weather the coming storm. Others are less sure.

“For the hospitals, it depends on who is in charge — what camp your leadership is in,” an anesthesiologist on the East Coast, speaking on the condition of anonymity, told STAT. “There’s been the ‘just the flu’ contingent, and everyone else.”

Terry Adirim, a trained pediatric emergency physician who helps lead clinical care at Florida Atlantic University College of Medicine, agreed that there is “variability in preparedness” that has to do with hospital leadership. But the former senior Department of Defense and Homeland Security official added, “I think that comes because federal guidances haven’t been as strong as they

You’re reading a preview, subscribe to read more.

More from STAT

STAT2 min read
STAT+: Brain Biopsies On ‘Vulnerable’ Patients At Mount Sinai Set Off Alarm Bells At FDA, Documents Show
A STAT Investigation: Brain biopsies on "vulnerable" patients at Mount Sinai set off alarm bells at FDA, documents show.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About A Senate Probe Into Novo Pricing, A New UTI Antibiotic, And More
The U.S. Senate health committee is investigating the prices Novo Nordisk charges for its blockbuster medications Ozempic and Wegovy.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About CVS And Humira Biosimilars, Schumer’s Broken Insulin Promise, And More
New prescriptions for biosimilar versions of Humira, one of the best-selling drugs in the U.S., surged to 36% from just 5% during the first week of April.

Related Books & Audiobooks